JP2004525928A5 - - Google Patents

Download PDF

Info

Publication number
JP2004525928A5
JP2004525928A5 JP2002574739A JP2002574739A JP2004525928A5 JP 2004525928 A5 JP2004525928 A5 JP 2004525928A5 JP 2002574739 A JP2002574739 A JP 2002574739A JP 2002574739 A JP2002574739 A JP 2002574739A JP 2004525928 A5 JP2004525928 A5 JP 2004525928A5
Authority
JP
Japan
Prior art keywords
dosage form
nicotine
sugar alcohol
active
combinations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002574739A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004525928A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/008914 external-priority patent/WO2002076211A1/en
Publication of JP2004525928A publication Critical patent/JP2004525928A/ja
Publication of JP2004525928A5 publication Critical patent/JP2004525928A5/ja
Pending legal-status Critical Current

Links

JP2002574739A 2001-03-26 2002-03-22 ニコチン含有経口剤形 Pending JP2004525928A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27860601P 2001-03-26 2001-03-26
PCT/US2002/008914 WO2002076211A1 (en) 2001-03-26 2002-03-22 Nicotine-containing oral dosage form

Publications (2)

Publication Number Publication Date
JP2004525928A JP2004525928A (ja) 2004-08-26
JP2004525928A5 true JP2004525928A5 (enExample) 2005-12-22

Family

ID=23065632

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002574739A Pending JP2004525928A (ja) 2001-03-26 2002-03-22 ニコチン含有経口剤形

Country Status (11)

Country Link
EP (1) EP1372392A4 (enExample)
JP (1) JP2004525928A (enExample)
CN (2) CN1553771A (enExample)
AR (1) AR033444A1 (enExample)
AU (1) AU2002252470B2 (enExample)
BR (1) BR0208382A (enExample)
CA (1) CA2440713A1 (enExample)
MX (1) MXPA03008762A (enExample)
NZ (1) NZ528167A (enExample)
PL (1) PL364621A1 (enExample)
WO (1) WO2002076211A1 (enExample)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Insomnia treatment
PL2446881T3 (pl) * 2003-07-24 2014-08-29 Glaxosmithkline Llc Folie rozpuszczające się w jamie ustnej
GB0320854D0 (en) 2003-09-05 2003-10-08 Arrow No 7 Ltd Buccal drug delivery
US20070191815A1 (en) 2004-09-13 2007-08-16 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery
CN104397869B (zh) 2003-11-07 2016-06-08 美国无烟烟草有限责任公司 烟草组合物
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
BRPI0514283A (pt) * 2004-08-11 2008-06-10 Cadbury Adams Usa Llc composições para aquecimento e sistemas de liberação para as mesmas
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
MX2009005671A (es) * 2006-12-01 2009-06-08 Cima Labs Inc Forma de dosificacion de nicotina transmucosal oral.
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
ES2521494T3 (es) 2007-04-02 2014-11-12 Parkinson's Institute Métodos y composiciones para la reducción de los efectos secundarios de tratamientos terapéuticos
DE102008012015A1 (de) * 2008-03-01 2009-09-10 Südzucker AG Mannheim/Ochsenfurt Verbesserte Isomalt-haltige Komprimate und Verfahren zu ihrer Herstellung
MX2012009586A (es) * 2010-02-18 2012-09-12 Jatin Vasant Thakkar Patillas de gelatina blanda con nicotina.
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
UA112974C2 (uk) * 2010-09-16 2016-11-25 Джеі. Бі. Кемікалс Енд Фармасьютікалс Лімітид Нікотиновмісна композиція (варіанти)
US20130017259A1 (en) 2011-07-06 2013-01-17 The Parkinson's Institute Compositions and Methods for Treatment of Symptoms in Parkinson's Disease Patients
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) * 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US9044035B2 (en) * 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
AR096223A1 (es) * 2013-05-10 2015-12-16 Glaxosmithkline Llc Pastilla de nicotina para administración oral
CN104132895B (zh) * 2014-07-08 2017-08-25 国家烟草质量监督检验中心 适用于连续流动法测定烟草及烟草制品中总植物碱的缓冲体系
WO2016123406A1 (en) 2015-01-28 2016-08-04 Chrono Therapeutics Inc. Drug delivery methods and systems
EP3267875A4 (en) 2015-03-12 2018-12-05 Chrono Therapeutics Inc. Craving input and support system
WO2018129304A1 (en) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Transdermal drug delivery devices and methods
SE541358C2 (en) * 2017-05-30 2019-08-13 Enorama Pharma Ab Nicotine-containing chewing gum compositions
CA3101966A1 (en) 2018-05-29 2019-12-05 Morningside Venture Investments Limited Drug delivery methods and systems
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
DK3826477T3 (da) * 2019-06-07 2023-12-11 Philip Morris Products Sa Poseprodukt med flydende smagssammensætning
CA3167882A1 (en) * 2020-01-15 2021-07-22 Mcneil Ab Lozenge
USD1081739S1 (en) 2021-04-06 2025-07-01 Altria Client Services Llc Die for gum forming
US20220313678A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Spray dried nicotine for inclusion in oral products
US20220313614A1 (en) * 2021-04-06 2022-10-06 Altria Client Services Llc Encapsulated nicotine granules and methods of preparation thereof
US12295412B2 (en) 2022-01-28 2025-05-13 Altria Client Services Llc Oral pouch product

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9310412D0 (en) * 1993-05-20 1993-07-07 Danbiosyst Uk Nasal nicotine system
US5549906A (en) * 1993-07-26 1996-08-27 Pharmacia Ab Nicotine lozenge and therapeutic method for smoking cessation
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
DE19536394A1 (de) * 1995-09-29 1997-04-03 Basf Ag Feste Arzneiformen, erhältlich durch Extrusion einer Isomalt enthaltenden Polymer-Wirkstoff-Schmelze
DE19639342C2 (de) * 1996-09-25 1998-07-16 Suedzucker Ag Kaugummi, enthaltend ein Süßungsmittel
US6322806B1 (en) * 1999-04-06 2001-11-27 Wm. Wrigley Jr. Company Over-coated chewing gum formulations including tableted center

Similar Documents

Publication Publication Date Title
JP2006503046A5 (enExample)
EP1082106B1 (en) Effervescent tablet for the sublingual, buccal and gingival administration of fentanyl
JP2006516648A5 (enExample)
AU2002252470B2 (en) Nicotine-containing oral dosage form
US20040101543A1 (en) Nicotine-containing oral dosage form
JP2007523091A5 (enExample)
AU2003267268B2 (en) Modified release oral dosage form
AU627775B2 (en) Pharmaceutical compositions
RU2000107784A (ru) Препараты для орального введения
AU2002252470A1 (en) Nicotine-containing oral dosage form
UA57615C2 (uk) Тверда шипуча швидкорозчинна композиція цетиризину
CA2470464A1 (en) Use of heliopsis longipes extract in oral compositions
WO1996000070A1 (en) Treatment of nicotine craving and/or smoking withdrawal symptoms with an oral composition containing nicotine and caffeine or xanthine
UA53714C2 (uk) Спосіб отримання таблеток флурбіпрофену
FI4288036T3 (fi) Plasman kallikreiinin estäjän formulaatioita
JP2002332229A (ja) 感冒用組成物
US10016359B2 (en) Solid forms containing meloxicam with improved buccal taste and process for their preparation
JP2004043475A (ja) 経口用セファロスポリン製剤
ES2242940T3 (es) Prucaloprida n-oxido.
JP2005503429A5 (enExample)
ES2215025T3 (es) Formulacion farmaceutica efervescente, que contiene metamizol.
US20070248667A1 (en) Tannate Compositions and Methods of Use
CZ122593A3 (en) Pharmaceutical preparation
JP2005507409A5 (enExample)
JP2001199894A (ja) 緩下剤